Summary
Introduction
Overweight and obesity are major public health problems, 1 representing the fifth leading cause of death in the world 2 and an increasing global challenge. 3 Obesity has severe impacts on health, increasing the risk of type 2 diabetes, hypertension, some cancers, heart and liver disease. 1, 4 5 The Foresight Report 6 estimated the National Health Service costs attributable to obesity in 2007 as £4.2 billion. In 2010, 68% of men and 58% women in England were overweight or obese (Body Mass Index (BMI) ≥25 kg/m 2 ). 7 Obesity is a chronic condition requiring lifelong management as weight loss is often regained. 8, 9 Achieving changes in behaviour is challenging, 10 largely due to an inability to maintain healthy eating and physical activity behaviours. 11 Modest weight loss (3-9%) can prevent type 2 diabetes, improve fasting plasma glucose, blood pressure and lipids, and reduce antihypertensive medication. 12, 13 14-16 Most overweight patients would like help with weight management from their general practices, 17 and this is feasible in the short-term (3-12 months) 18, 19 and estimated to be cost saving to the NHS, 20 although few recall receiving weight control advice from a health professional. 21 The aim of this study was to develop and evaluate the efficacy of an intervention programme with twelve months follow up, for an ethnically diverse overweight/obese population recruited from general practices in a pragmatic randomised controlled trial following the Medical Research Council framework for complex interventions. 22 To our knowledge, there are currently no other published randomised controlled trials of one-to-one lifestyle intervention delivered in UK general practice to overweight/obese patients without co-morbidities.
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Methods
Aims
The aim of the study was to assess, by means of a pragmatic parallel group randomized controlled trial (RCT), the effects on anthropometric measures, health-related parameters and the sense of well-being of offering individualized weight management advice in primary care to overweight/obese people who wished to lose weight; and to identify the key factors influencing the outcome of the intervention.
The primary outcomes were the differences between the control and intervention groups in changes in body weight, waist circumference, percent body fat, blood pressure and heart rate from baseline to 12 months and proportion who lost 5% of their baseline weight.
Interventions
The intervention combined evidence-based components recognized as essential for behaviour change and successful weight loss, 23 : healthier eating, increased physical activity incorporated into patients' everyday lifestyles, tailored goal setting, keeping food and activity diaries, self-monitoring, positive reinforcement, coping with lapses and high-risk situations and long-term support -and derived from theoretical frameworks underpinning health promotion that have an emphasis on long-term changes in habits. This includes, for example, social cognitive theory 24 which addresses diet and activity-related social support, outcome expectations, self-efficacy and self-regulation as well as diet and physical activity monitoring to assess changes over time; goal setting. 25 It also has an emphasis on SMART (Specific, Measurable, Attainable, Relevant, Timely) goal setting, the relationship between goals and satisfaction and the achievement of goals and rewards; and systems thinking 26 which focuses on environmental changes and emphasizes long-term changes in routines. The programme also incorporated NICE guidance on management of overweight and obesity 27 as well as evidence-based principles of behaviour modification, 23 adherence to treatment 28 and results from our pilot study ( Figure 1 ). 18 Six CAMWEL advisors were recruited from various occupational backgrounds including healthcare, in line with the NHS health trainers initiative. 29 The advisors received initial training over two days, and further meetings with the research team every three to four months. Training of advisors included briefing on the obesity epidemic; food and physical activity behaviours associated with excess weight; principles of best practice and behaviour change strategies; evidence for what has been shown to work in weight loss management programmes; the use of motivational interviewing methods, counselling techniques and cognitive behaviour therapy methods to provide tailored support for behaviour change; together with details of the study design and role play. All advisors were given a copy of the National Obesity Forum CD-Rom 'Managing Obesity in Primary Care'. Participants were invited to attend 30-minute sessions with the advisor every fortnight for the first 12 weeks, three-weekly for 12 weeks, and finally monthly for the next 12 weeks, making a total of 14 sessions. A script and schedule of topics for discussion were provided to the advisors for each session. The topics included: personally agreed weight loss goals, eating and physical activity goals; exploration of motivations for losing weight; personal cues to reduce unhealthy eating and sedentary behaviour; support from family and friends; triggers associated with habits and routines; long-term benefits of small changes; and the importance of scheduling and time management. A commercially available weight management software package (http://www.perfect-diet-tracker.com) was used to record and monitor participant progress and keep notes of each session by the advisors. The advisors were provided with access to a book giving the calorie content of foods available in the UK, 30 a kit including 100 calorie portions of various food items, Adams Food and Alcohol Portion Pots (www.adamsportionpot.com). The intervention participants were given pedometers and handouts associated with each session, including a tailored motivational booklet to encourage increased levels of physical activity and a book of walks in the local area specially prepared for the study (Appendix 1). Further details are available from the corresponding author (KN).
There is no current comparator 'gold standard' treatment programme available for weight management in general practice. In this pragmatic trial of a complex intervention, we assess the benefit of the intervention compared to routine clinical practice. We provided a copy of the Quick reference NICE clinical guideline on Obesity to all participating GPs 27 and asked control participants to contact their general practice to receive usual weight management care provided by the practice, which could include referral to a dietitian (http://www.camden.nhs.uk/adult-weight-management-service.htm), exercise on referral, the "Shape-Up" programme (http://camden.gov.uk/ccm/navigation/leisure/sport-and-physicalactivity/get-active-and-healthy/lose-weight/) , prescription of weight loss medication, weight loss surgery or no further treatment.
All participants were given the British Heart Foundation (BHF) booklet: 'So you want to lose weight … for good'.
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Recruitment
All general practices in Camden were visited and invited to participate in the trial. Participants were recruited between July 2009 and January 2010 from 23 of 39 NHS Camden general practices. The London Borough of Camden has areas of relative affluence alongside areas of relative deprivation, with approximately 35% of the population living in areas classified as some of the most deprived in England. 32 Education levels are also disparate, with 47% of people in employment being educated to degree level or above, whilst 17% of working age people have no qualifications. 33 Camden has an ethnically diverse population, with 27% belonging to minority ethnic groups.
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Several recruitment approaches were used. Primarily, participating practices wrote to a sample of patients with body mass index (BMI) ≥25 kg/m 2 ; GPs and Practice Nurses (PNs) were provided with referral 'prescription' pads with a tear-off slip to be given to the patient with contact details of the trial office; and posters and flyers were placed in practice waiting areas and local pharmacies. During the final six weeks of the recruitment period, three practices supplemented recruitment by sending text messages to potentially eligible patients using their electronic record (EMIS) and messaging (iPLATO) systems. All practices were reimbursed for time spent on recruitment.
Baseline measurements
Potential participants were screened by telephone for eligibility (MH, EH, TP). Inclusion criteria were age 18 years and above, BMI≥ 25 kg/m willing to attend visits with a CAMWEL advisor over 12 months. Exclusion criteria were pregnancy or lactation, diagnosis of renal failure, use of a pacemaker, recent diagnosis of cancer, or participation in another weight management study. Following GP consent, participants were scheduled for screening appointments with a researcher (MH) at one of three practices. The study was explained and the participant invited to give informed written consent and to complete the baseline questionnaire. Height (without shoes) was measured to the nearest 0.1 cm using a stadiometer. Weight (in light clothing) was measured using the Tanita (BC 420 MA) scales. The scales also reported percent body fat, basal metabolic rate and metabolic age (age expected for a given value of basal metabolic rate). Waist was measured mid-way between the iliac crest and the costal margin to the nearest 0.1 cm. Blood pressure and heart rate were measured using a digital automatic monitor (Omron Model M10-IT), with the average of three readings recorded where possible. The printout from the Tanita scales, including weight, BMI and metabolic age, was given to all participants.
Outcomes
All participants were invited for follow up at 6 and 12 months. A letter was sent three weeks prior to the due date, followed by a telephone call to arrange the appointment. Three attempts were made to contact each participant. Measurements taken at baseline were repeated and participants were asked to complete a questionnaire. A £30 voucher was provided for their time to all participants who completed each follow-up appointment.
The self-completed questionnaires included the following validated measures: EuroQol Visual Analogue Scale (EQ-VAS), Obesity and Weight Loss Quality-of-Life (OWLQOL) 34 ; Hospital Anxiety and Depression Scale (HADS) 35 ; Rosenberg measure of self-esteem 36 ; Duke-UNC Functional Social Support Questionnaire (FSSQ) 37 ; Three-Factor Eating Questionnaire (TFEQ-18) 38 ; and physical activity (RPAQ) 39 ; as well as socio-demographic information. Deprivation was ascertained using the Index of Multiple Deprivation (IMD) based on the participant's home address post code. 40 In addition, at follow-up we used the Patient Assessment of Care for Chronic Conditions (PACIC) 41, 42 to assess the participants' views on the care they received from the advisors and the GP practice on helping them lose weight. A brief series of statements was used to assess participants' confidence in their ability to manage their weight on a scale of one (disagree strongly) to four (agree strongly). Further questions asked about the type of help received from the GP practice regarding weight loss, changes made in behaviours related to weight management, and experience of study participation. Participants in the intervention group also completed an additional section to ascertain how helpful they found the sessions and materials provided as part of the CAMWEL programme.
Randomization
Participants were randomly allocated (allocation ratio 1:1) to the control or intervention group (TP, EH, AS), using a computer-generated randomization application written in VBA for MS Access (TP). The Taves method of minimization 43 was used to ensure the groups were balanced for general practice, gender, age group (≤50/ >50 years), BMI category (≤30/>30 kg/m
The study was single-blinded with members of the study team assessing baseline and follow-up measurements blinded to group assignment.
Sample size
In our pilot study participants had a mean weight of 98.1 kg (SD 17.3 kg) at baseline. 18 Since a loss of 5-10% of body weight in obese adults is associated with significant reductions in the risk of obesity co-morbidities, we considered a difference in weight between groups of 7% at 12 months follow-up to be clinically important. For the sample size calculation, we wished to detect a mean weight difference of 6.9 kg at 12 months between the two groups with two-sided statistical significance of 1%, power at 90%, and the correlation coefficient between baseline and follow-up values conservatively set at 0.7. We thus calculated a total sample size of 228 (114 per group). Assuming a loss to follow up at 12 months of 40%, 44 it was estimated that 380 participants would be required.
Statistical methods
Comparisons between groups for continuous variables were performed using two-sample ttests and regression methods, adjusting for the baseline value of the variable. Chi-sq tests and logistic regression were used for categorical variables. Changes were calculated as value at follow-up minus baseline value. Primary analyses were conducted on an intentionto-treat basis, using multiple imputation (MI) to account for missing data at follow-up. Exclusion of subjects with missing data is inefficient and can lead to biased results if those dropped are atypical in some respect 45 and MI can both increase efficiency and reduce bias in such settings. 46, 47 Missingness in this study is dominated by attrition, but there are also some intermediate missing outcome values and missing baseline values (although not for weight) so the 'Fully Conditional Specification' form of MI has been used. 48 For each outcome, the full set of imputation variables comprised the outcomes at each of the three occasions, together with a set of baseline variables selected for their non-negligible association with missingness or weight loss. For all outcomes the following baseline variables were included: age, weight, percent body fat, BMI, fat mass, metabolic age, deprivation status and employment status as well as totals from the OWLQOL, EQVAS, HADS anxiety, TFEQ emotional eating and RPAQ scales. The imputation procedure was carried out separately for the two groups (intervention and control) and the resulting multiply imputed datasets were combined for the final MI analysis. A total of 200 imputations were used to stabilize the results and to ensure negligible loss of power. 45 Analyses using only data on participants who completed 12-month follow-up were also conducted.
Exploratory analyses were conducted excluding subjects who had bariatric surgery or were prescribed weight loss medication during the course of the trial. We also examined whether the degree of weight loss was associated with baseline characteristics or with changes in health or quality of life measures. Analyses were performed using STATA version 11.
Ethical approval
The study was approved by the London School of Hygiene & Tropical Medicine Ethics Committee, the Camden and Islington Community Research Ethics Committee (reference number 09/H0722/22) and the North Central London Research Consortium.
Results
Participants were followed up at 6 months between January 2010 and July 2010; and at 12 months between July 2010 and January 2011. Participant flow through the trial is shown in Figure 2 .
Baseline characteristics
We recruited 381 participants with a median age of 48.5 years (inter-quartile range 37.5 to 60.4), weighing 60.1 to 152.2 kg, with waist circumference of 76 to 147 cm. The majority (72%) were women, 12% (47/381) had diagnosed diabetes, 1.3% (5/381) were on antipsychotic medication, 60% were in employment, 47% were university graduates and 73% described their ethnicity as white (Table 1 ). Participants wanted to lose an average of 18 kg (sd = 12.4), representing 16.7% of their baseline weight. There were no significant differences between groups for any of these variables.
Response rates
Measurements were obtained for 69% (n=263) of the sample at 6 months and 57% (n=217) at 12 months. There were no significant differences in follow-up rate at 12 months by randomisation group (60.0% control, 53.9% intervention, P=0.23), but those followed up tended to be older, have lower BMI, fat mass and percent body fat, and were less likely to be from a deprived area than those not followed up (Table 2) .
Primary Outcomes
Based on the intention-to-treat analysis using imputed missing values (Table 3) , at 12 months follow-up structured support resulted in a mean difference in weight loss between the two groups of -0.70 (-2.71 to 0.76) kg. A higher proportion of participants lost 5% or more of their baseline weight in the intervention when compared to usual care group (odds ratio 1.73 (1.38 to 2.66, P=0.04). The intervention programme was also associated with weak evidence of beneficial trends in waist circumference, percent body fat, and percent weight change. Heart rate was reduced by 3.7 (0.3 to 7.0, P=0.03) beats per minute in the intervention group compared to the control group.
Based on data for participants who completed the 12-month follow-up (Table 3 ) a higher proportion (one in three compared to one in five) in the intervention group had lost at least 5% of their initial weight (difference 14.7% (3.0 to 26.4, P=0.01)) and experienced a greater average reduction in waist circumference (difference 1.88 cm (0.01 to 3.76, P=0.05)) compared to those in the control group. Weak evidence of reductions in weight, %body fat, BMI, blood pressure and heart rate were observed in the intervention compared to the control group. The absolute risk reduction for losing 5% baseline weight was 14.7 % (3.0 to 26.4) and the number needed to treat was 6.8 (3.8 to 33.2). A higher proportion of those in the intervention group (84%, 21/25) who had lost ≥5% at 6 months had managed to keep this level of weight loss at 12 months compared to those in the control group (61.5%, 8/13). We were unable to identify characteristics of the sub-group of participants more likely to lose 5% of their baseline weight.
Secondary Outcomes
No evidence of differences was found between the two groups on any of the psychological or quality of life measures.
Trial participation
Participants in the intervention group were more satisfied than those in the control group with the level of weight loss achieved and they found participation in the trial and feedback of physical measurements helpful ( Table 4 ). The intervention group also reported receiving more patient centred care than those in the control group as measured by the PACIC scales (Table 5 ). Detailed analysis of the interviews and focus groups with a sub-set of the participants will be reported elsewhere.
The intervention programme
Participants reported that regular meetings with the advisor was the most helpful aspect of the programme; the least helpful was the handouts provided ( Table 6 ). The most helpful sessions were the first (getting started), eighth (positive thinking) and twelfth (staying active). The most helpful handouts were 'Rate Your Plate', 'CAMWEL Walks' and 'Staying Active', the least helpful were 'Building A Better Recipe' and 'Meal Plans'. The majority (84%) said they would choose to continue to meet an advisor beyond the 12 months of the current study, with most (73%) preferring to see the advisor at least every four weeks.
Behaviours associated with losing 5% or more of baseline weight Participants who lost 5% or more of their baseline weight were more likely to state that they had reduced their fat and sugar intake in the previous six months than those who did not; there was no evidence of increasing levels of physical activity between the groups (Table 7) . They also reported that attending regular meetings with a non-judgmental advisor, discussion on portion sizes and use of the pedometer were particularly useful and would continue to monitor food intake to maintain their weight.
Exploratory analysis 38 participants were known to have been prescribed drugs for weight loss or to have undergone weight loss surgery during the trial period. Of these, 27 were followed up at 12 months (12 control: mean weight change -2.44 kg (-7.15 to 2.27); 15 intervention: mean weight change -3.51 kg (-6.95 to -0.08)). The difference between groups was 1.07 kg (-4.32 to 6.46, p = 0.69). In analysis excluding these participants, those in the intervention group showed significantly greater reductions in weight (1.72 kg (0.29 to 3.14, P= 0.02)), waist circumference (2.52 cm (0.32 to 4.72, P=0.03)), BMI (0.63 kg/m2 (0.11 to 1.14, P=0.02)) and percent baseline weight loss (1.94% (0.32 to 3.56, P=0.02)) when compared with the control group at 12 months. In addition, a higher proportion of participants in the advisor group lost ≥5% of their baseline weight when compared to the control group (odds ratio 2.68 (1.13 to 5.70, P=0.03)).
The number of sessions attended was available for 87 participants of whom 40 > (46%) attended more than 70% (10/14) of the available sessions. Half (50%) of the participants attending more than 70% of the programme lost 5% or more of their baseline weight compared to a quarter (23%) who attended fewer sessions (difference 26.5%; 95%CI: 6.9 to 46.3; p=0.01).
Discussion
Principal findings
The structured one-to-one weight loss programme delivered by non-specialists in general practice did not achieve the pre-specified difference in average weight loss of 7%. However it did result in a higher proportion of the participants losing 5% or more of their baseline weight compared to those randomized to usual care (odds ratio 1.73 (1.38 to 2.66)) which is considered a clinically important outcome in similar trials. This suggests that people likely to benefit from such a programme are a subset of the total study population but we were unable to identify particularcharacteristics that would permit identification of a receptive group in advance. There was some evidence that the intervention group experienced greater reductions in mean weight, waist circumference and % body weight than the control group. While the overall effects on weight loss are modest they are not unimportant.
Strengths and weaknesses of the study
The key strengths of the CAMWEL programme are its wide applicability to overweight and obese people from diverse backgrounds as there were few exclusions, feasibility of its delivery in primary care by non-specialist trained advisors and a patient-centred approach to making sustainable changes to diet and physical activity easily incorporated into peoples' daily lives.
Limitations include the slow initial recruitment although this improved over time, particularly with mobile phone text message use. 49 Loss to follow up was high (43%) although similar to that of other weight loss studies in the UK. 50 , 51 52 53 The response rate in the DESMOND diabetes management trial 19 was substantially higher (91%), perhaps because participants were recently diagnosed diabetics and therefore highly motivated. High attrition in RCTs of weight loss is well recognized, 54 with a recent review reporting losses to follow-up of 30-60%. 44 We used multiple imputation for missing values in primary outcomes to counter any biases due to loss to follow-up as high level of attrition involves considerable uncertainty about outcomes for participants lost to follow-up. We included patients with BMI≥25 as NICE recommends treatment at this level although this relatively low threshold and broad inclusion criteria may have diluted the results in terms of average weight loss thus needing a larger sample to detect significant differences.
Participants in the control group were advised to contact their general practice to receive the usual care provided for weight loss. We provided all GPs with NICE guidelines on obesity and participants with the BHF booklet on weight loss as well as feedback on the measurements taken at six months. This provision of support could be one reason why participants in the control group also lost weight over the period of the trial which resulting in greater similarity of changes in the two groups and would represent bias if the GPs altered their usual care by virtue of trial participation. Another study 55 suggested participants may be disappointed by allocation to usual care when they had entered the trial with preferences for allocation to the intervention group. The response to disappointment may trigger behaviour change and contribute to the weight loss seen in the control group and thus entail performance bias (McCambridge, personal communication).
Behaviour change interventions tend to be complex with multiple components and it is difficult to assess the effectiveness of different components. This was a pragmatic trial reflecting the likely performance of the programme as delivered in practice. While the fidelity of the delivery of the intervention could be examined in more detail, we have shown that patient assessment of the structured support by trained advisors is significantly better than usual care.
Cost-effectiveness analyses are required to inform decision-making about the value of attaining these outcomes and will be reported in a separate paper.
Putting the study in context
Seven published RCTs of similar interventions conducted in UK general practice have been conducted (see Table 8 ). With the exception of a trial in newly diagnosed diabetics, these provided no strong evidence of differences in weight loss between intervention and control groups, except for those using a commercial provider (Weight Watchers). Our trial achieved results at least comparable with the more targeted interventions based in general practice.
Implications
We have demonstrated that one-to-one structured support by a trained advisor in general practice can help people wishing to lose weight to change their behaviour sufficiently to lead to a clinically important loss in weight. Understanding how the intervention worked and why it worked just for some participants as well as its cost-effectiveness are important and we will explore these in our subsequent research. The importance of our results lies in their generalisability. Our results, together with those from other researchers, suggest that individual approaches in general practice can achieve modest benefits for the National Health Service. However, primary care interventions are unlikely to be sufficient to address the obesity epidemic and effective population wide policy measures are needed as well, including increasing energy expenditure through active travel 56 and reducing dietary intake.
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